Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Extranodal NK-T-Cell × Drug Therapy × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasms 2 NSCLC 2 Lymphoma, Non-Hodgkin 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Solid Tumor Regardless of Localization and Stage 1 Patient Acceptance of Health Care 1 Pancreatic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Multiple Myeloma 1 Lymphoma, Extranodal NK-T-Cell 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 HER-2 Negative Breast Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Acute Kidney Injury 1

Interventions

Gemcitabine 2 Etoposide 2 Cisplatin 2 ruxolitinib 1 pegaspargase 1 Radiotherapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Drug Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01501136 2015-07-17

CTTNKTL-I/II

Zhengzhou University

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡